Streetbeat News

Regulatory

META

Meta Platforms Inc. (NASDAQ:META) is under scrutiny for running ads on Facebook and Instagram that promote illegal drugs, violating its own policies. The ads, which include images of drugs and redirect users to other platforms for purchases, have led to a federal investigation. Meta has removed the ads and banned the users who created them.

Portfolio Pulse from Benzinga Neuro

July 31, 2024 | 2:23 pm

INFY

Infosys has been found liable to pay a tax amount of INR 324.03 billion, according to a document from the tax authority cited by Reuters.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 2:06 pm

TPHS

On July 30, 2024, Trinity Place Holdings received a notice from NYSE Regulation that trading of its common stock has been suspended and proceedings to delist the stock from NYSE American have commenced.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 2:03 pm

LYFT

UBER

The NYC Taxi and Limousine Commission has agreed not to impose new regulations on ride-hailing companies Uber and Lyft, according to Bloomberg.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 1:57 pm

AMD

SMCI

Super Micro Computer Inc (NASDAQ:SMCI) shares are surging in sympathy with Advanced Micro Devices, Inc. (NASDAQ:AMD), which reported strong Q2 financial results. AMD's revenue and earnings beat analyst estimates, driven by record Data Center segment revenue and accelerating AI business. AMD's positive outlook for Q3 and GPU revenue has boosted investor optimism in semiconductor stocks, including SMCI. Additionally, potential new US rules to limit semiconductor equipment exports to China may also be influencing the sector.

Portfolio Pulse from Adam Eckert

July 31, 2024 | 1:24 pm

ABCL

LLY

AbCellera (NASDAQ:ABCL) and Eli Lilly (NYSE:LLY) have expanded their collaboration to develop therapeutic antibodies for immunology, cardiovascular disease, and neuroscience. This builds on their successful partnership since March 2020, which included eight de novo programs and a COVID-19 antibody program that received emergency use authorization from the FDA.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 1:11 pm

RYTM

VGK

Rhythm Pharmaceuticals has received European Commission approval to expand the marketing authorization of IMCIVREE to include children aged 2-5 with obesity due to Bardet Biedl Syndrome or POMC, PCSK1, and LEPR deficiency.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 1:11 pm

TSLA

Tesla's Full Self-Driving (FSD) system is under scrutiny following a fatal motorcycle accident near Seattle involving a 2022 Tesla Model S. The driver admitted to using the Autopilot system and being distracted by his cellphone. The incident raises questions about the safety of Tesla's self-driving technology.

Portfolio Pulse from Benzinga Neuro

July 31, 2024 | 1:10 pm

BIIB

IONS

Alcyone Therapeutics has received FDA approval to continue enrollment in the PIERRE pivotal IDE clinical study of the ThecaFlex DRx System for administering nusinersen to SMA patients. The first stage of the trial showed no device-related adverse events, and the study will now expand to include 80 additional patients across 30 centers.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 1:08 pm

CLVR

KHRNF

PCLOF

The article discusses the potential for cannabis legalization in Venezuela amid political turmoil and election fraud allegations. It highlights the successes of Colombia's cannabis industry and mentions companies like Clever Leaves Holdings Inc, Khiron Life Sciences Corp, and PharmaCielo Ltd as examples of successful cannabis businesses in Colombia.

Portfolio Pulse from Patricio Liddle

July 31, 2024 | 1:02 pm